These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9856687)

  • 1. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention.
    Fernandez CV; Esau R; Hamilton D; Fitzsimmons B; Pritchard S
    J Pediatr Hematol Oncol; 1998; 20(6):587-90. PubMed ID: 9856687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases.
    Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B
    Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.
    Alcaraz A; Rey C; Concha A; Medina A
    J Toxicol Clin Toxicol; 2002; 40(5):557-61. PubMed ID: 12215050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".
    Walter AW
    J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422
    [No Abstract]   [Full Text] [Related]  

  • 5. Two Fatal Cases of Accidental Intrathecal Vincristine Administration: Learning from Death Events.
    Chotsampancharoen T; Sripornsawan P; Wongchanchailert M
    Chemotherapy; 2016; 61(2):108-10. PubMed ID: 26636546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal myeloencephalopathy due to intrathecal vincristine administration.
    al Fawaz IM
    Ann Trop Paediatr; 1992; 12(3):339-42. PubMed ID: 1280054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accidental intramuscular vincristine: lack of untoward effects and recommendations for management.
    Clark BS; Gallegos E; Bleyer WA
    Med Pediatr Oncol; 1997 Apr; 28(4):314-5. PubMed ID: 9078327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatality resulting from intraventricular vincristine administration.
    Meggs WJ; Hoffman RS
    J Toxicol Clin Toxicol; 1998; 36(3):243-6. PubMed ID: 9656982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accidental administration of vincristine into the brachial artery.
    Jackson N; Hassan NB
    Clin Oncol (R Coll Radiol); 1997; 9(3):198. PubMed ID: 9269559
    [No Abstract]   [Full Text] [Related]  

  • 10. Inadvertent intramuscular administration of vincristine: lack of untoward effects without any treatment except administration of hot compresses.
    Olcay L; Safak T
    Pediatr Hematol Oncol; 2003; 20(5):427-8. PubMed ID: 12775543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural toxicity induced by accidental intrathecal vincristine administration.
    Kwack EK; Kim DJ; Park TI; Cho KR; Kwon IH; Sohn YK
    J Korean Med Sci; 1999 Dec; 14(6):688-92. PubMed ID: 10642952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal myeloencephalopathy caused by intrathecal vincristine.
    Slyter H; Liwnicz B; Herrick MK; Mason R
    Neurology; 1980 Aug; 30(8):867-71. PubMed ID: 6893362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature.
    Pongudom S; Chinthammitr Y
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S258-63. PubMed ID: 21721457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error.
    Williams ME; Walker AN; Bracikowski JP; Garner L; Wilson KD; Carpenter JT
    Cancer; 1983 Jun; 51(11):2041-7. PubMed ID: 6573227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report.
    Qweider M; Gilsbach JM; Rohde V
    J Neurosurg Spine; 2007 Mar; 6(3):280-3. PubMed ID: 17355029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal vincristine: 3 fatal cases and a review of the literature.
    Hennipman B; de Vries E; Bökkerink JP; Ball LM; Veerman AJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):816-9. PubMed ID: 19801949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing vincristine administration errors: Does evidence support minibag infusions?
    Schulmeister L
    Clin J Oncol Nurs; 2006 Apr; 10(2):271-3. PubMed ID: 16708708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not again! Erroneous intrathecal injection results from a problem with protocols.
    Seale JR
    BMJ; 2001 Mar; 322(7285):548. PubMed ID: 11230084
    [No Abstract]   [Full Text] [Related]  

  • 19. Inadvertent intrathecal administration of vincristine: has anything changed?
    Gilbar P
    J Oncol Pharm Pract; 2012 Mar; 18(1):155-7. PubMed ID: 21965437
    [No Abstract]   [Full Text] [Related]  

  • 20. Safe vincristine use in Switzerland: Still a long way to go?
    Brühwiler LD; Schwappach DL
    J Oncol Pharm Pract; 2020 Jan; 26(1):51-59. PubMed ID: 30866715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.